Introduction of RU 486 in the USA: obstacles and opportunities.
Thoss
E
E
D000569:Americas; D001695:Biology; D003132:Commerce; D003257:Consumer Product Safety; D019049:Developed Countries; D004703:Endocrine System; D005060:Europe; D005193:Family Planning Services; D005602:France; D006077:Government Agencies; D006285:Health Planning; D006727:Hormone Antagonists; D006728:Hormones; D019359:Knowledge; D015735:Mifepristone; D009656:North America; D009934:Organization and Administration; D009938:Organizations; D010827:Physiology; D014481:United States; D014486:United States Food and Drug Administration; D014492:United States Public Health Service
D006727:Hormone Antagonists; D006728:Hormones; D015735:Mifepristone
Americas; Biology; Contraceptive Importation; Developed Countries; Endocrine System; Europe; Family Planning; Family Planning Program Administration; Family Planning Programs; France; Government Agencies; Hormone Antagonists; Hormones; Knowledge; Mediterranean Countries; North America; Northern America; Organizations; Physiology; Product Approval; Ru-486--legal aspects; United States; Usfda; Usphs; Western Europe